Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
AB-DIGEST
- Development stage
- Preclinical
- Lead developer
- AB-BIOTICS
- Modality
- Live Biotherapeutic Products → Microbiome Therapeutics
- Administration
- Oral
01
Overview
AB-DIGEST is a dietary supplement developed by AB-Biotics, formulated as a combination of specific probiotic strains, prebiotics (such as inulin and fructooligosaccharides), and the mineral zinc. It is designed to support and restore gut microbiota balance, thereby promoting overall gastrointestinal health and bolstering the immune system. The product is indicated for various digestive issues, including antibiotic-associated diarrhea, constipation, and for general gut microbiota restoration and immune support. It is available in different formats, including drops, sticks, and shots.
- Brand names
- AB-DIGEST
- Other names
- AB-DIGEST kids
Beyond the preview
Go deeper on AB-DIGEST.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on AB-DIGEST.